FDA Inspection
St. Charles Health SystemSt. Charles Health System – FDA Inspection, Sep 12, 2018
Record Details
This FDA Inspection record concerns St. Charles Health System, with an inspection on September 12, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · dbe090f5-cdaf-40f6-8ce3-cf6b80432e0b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1067783
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of St. Charles Health System
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 3, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 3, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 16, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 3, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 16, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for St. Charles Health System
- FDA Inspection 1235464 - 2024-04-03
- FDA Inspection 929846 - 2015-06-03
- FDA Inspection 841972 - 2013-07-16
- FDA Inspection 727985 - 2011-06-03
- FDA Inspection 614226 - 2009-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.